Bumrungrad Hospital Public Company Limited (BUHPF) Stock Analysis
Educational signal · not a buy or sell recommendation · How to read this
P/E 20.45 means the share price is 20.45 times one year of earnings per share; the S&P 500 usually sits near 20-25. Market cap $4.77B is the value of all shares combined.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 18, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerBumrungrad Hospital Public Company Limited (BUHPF) trades at $6.00. Bumrungrad Hospital Public Company Limited operates healthcare facilities in Thailand and internationally, offering a wide range of medical services. Market cap: $4.77B, Sector: Healthcare.
Price as of Sep 11, 2026 · Last analyzed: Mar 18, 2026Analyst Coverage for BUHPF: BUHPF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates BUHPF against Healthcare peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
No score published: this stock trades under $10,000 on a typical day, so the price beside it is not one you could reliably act on.
BUHPF: 2/2 scored disciplines lean bullish. Dominant signal: Ray Dalio bullish.
How is this calculated? →AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Bumrungrad Hospital Public Company Limited (BUHPF) Healthcare & Pipeline Overview
Bumrungrad Hospital, a leading healthcare provider based in Thailand, offers comprehensive medical services with a focus on international patients. Operating with 580 beds and numerous specialized clinics, the company distinguishes itself through high-quality care and advanced medical technologies, reflected in its strong profit margin of 29.8% and a substantial dividend yield of 8.41%.
What Is the Investment Thesis for BUHPF?
The company's high profit margin of 29.8% and dividend yield of 8.41% indicate financial stability and shareholder value. Key growth catalysts include increasing demand for healthcare services in Thailand and the expansion of its international patient base. The company's focus on specialized medical treatments and advanced technologies positions it favorably in a competitive market. However, potential risks include regulatory changes in the healthcare industry and economic fluctuations affecting patient affordability. The company's low beta of -0.07 suggests it is less volatile than the market, potentially offering a more stable investment option. Bumrungrad's ability to maintain its competitive edge through continuous innovation and service excellence will be crucial for sustained growth.
Based on FMP financials and quantitative analysis
BUHPF Key Highlights
Market Cap of $4.77B reflects Bumrungrad's significant presence and value in the healthcare industry.
- P/E Ratio of 20.45 suggests a reasonable valuation compared to its earnings.
- Profit Margin of 29.8% demonstrates strong operational efficiency and profitability.
- Gross Margin of 51.8% indicates effective cost management and pricing strategies.
- Dividend Yield of 8.41% provides a substantial return to investors, highlighting the company's commitment to shareholder value.
Who Are BUHPF's Competitors?
BUHPF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| AMFPF Amplifon S.p.A. | $11.21 | 0.00% | $2.97B | — |
| CZMWF Carl Zeiss Meditec AG | $39.96 | 0.00% | $3.50B | — |
| LVZPF Livzon Pharmaceutical Group Inc. | $5.22 | 0.00% | $6.06B | — |
| NHNKY Nihon Kohden Corporation | $10.01 | +4.71% | $3.20B | 489-signal |
| LFST LifeStance Health Group, Inc. | $13.00 | +3.01% | $5.04B | 945-pillar |
| MCVEF Medicover AB (publ) | $27.25 | 0.00% | $4.14B | 479-signal |
| MMED MiniMed Group, Inc. Common Stock | $22.42 | -0.11% | $6.30B | 385-pillar |
| OPCH Option Care Health, Inc. | $23.63 | -0.04% | $3.54B | 795-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.
What Are BUHPF's Key Strengths?
Strong brand reputation and international accreditation.
- Comprehensive range of medical services and specialized centers.
- Experienced medical professionals and staff.
- Strategic location in Bangkok, a hub for medical tourism.
What Are BUHPF's Weaknesses?
Dependence on international patients, making it vulnerable to travel restrictions and economic fluctuations.
- High operating costs associated with maintaining international standards.
- Competition from other healthcare providers in the region.
- Potential regulatory challenges in the healthcare industry.
What Could Drive BUHPF Stock Higher?
Expansion of specialized medical centers to attract more patients.
- Increasing demand for healthcare services in Thailand and the region.
- Growth in medical tourism and international patient services.
- Adoption of advanced medical technologies to improve treatment outcomes.
- Strategic partnerships and acquisitions to expand market reach.
What Are the Key Risks for BUHPF?
Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
- Economic downturns affecting patient affordability and demand for medical services.
- Changes in healthcare regulations and policies.
- Increased competition from other healthcare providers.
- Political instability and security risks in the region.
- Dependence on international patients, making it vulnerable to travel restrictions.
What Are the Growth Opportunities for BUHPF?
- Expansion of International Patient Services: Bumrungrad has a significant opportunity to further expand its services to international patients, particularly from regions with limited access to advanced medical treatments. By strengthening its marketing efforts and partnerships with international healthcare providers, Bumrungrad can attract a larger patient base seeking specialized medical care in Thailand. The global medical tourism market is projected to reach $272.7 billion by 2027, offering a substantial growth avenue for Bumrungrad.
- Development of Specialized Medical Centers: Investing in the development of specialized medical centers focused on specific medical disciplines, such as oncology, cardiology, and orthopedics, can attract more patients seeking advanced treatments. By offering comprehensive care within these specialized centers, Bumrungrad can enhance its reputation as a center of medical excellence and attract both domestic and international patients. This targeted approach allows for efficient resource allocation and specialized expertise.
- Adoption of Advanced Medical Technologies: Integrating advanced medical technologies, such as robotic surgery, AI-powered diagnostics, and telemedicine, can improve treatment outcomes and enhance patient experience. By investing in these technologies, Bumrungrad can attract patients seeking cutting-edge medical solutions and differentiate itself from competitors.
- Strategic Partnerships and Acquisitions: Forming strategic partnerships with other healthcare providers, insurance companies, and medical tourism agencies can expand Bumrungrad's reach and patient base. Acquiring smaller hospitals or clinics can also provide access to new markets and specialized services. These collaborations can enhance Bumrungrad's market presence and service offerings, driving revenue growth and market share.
- Enhancement of Digital Healthcare Services: Expanding digital healthcare services, such as online consultations, remote monitoring, and digital health records, can improve patient access and convenience. By offering these services, Bumrungrad can cater to a wider patient base and enhance patient engagement.
What Are BUHPF's Competitive Advantages?
- Established reputation and brand recognition as a leading healthcare provider in Thailand.
- Accreditation and international standards of medical care.
- Comprehensive range of medical services and specialized centers.
- Strategic location in Bangkok, a hub for medical tourism.
What Does BUHPF Do?
Founded in 1980 and headquartered in Bangkok, Thailand, Bumrungrad Hospital Public Company Limited has evolved into a prominent healthcare provider, offering a broad spectrum of medical services both domestically and internationally. The company operates a large medical center equipped with diagnostic, therapeutic, and intensive care facilities. Its extensive network includes approximately 56 outpatient clinics and centers, covering a wide array of specialties such as allergy, cardiology, oncology, orthopedics, and women's health. Bumrungrad distinguishes itself by catering to a diverse patient base, including a significant number of international patients seeking specialized medical treatments and services. Beyond its core hospital operations, Bumrungrad is involved in real estate asset management, clinical research services, and the distribution of pharmaceutical and medical goods through specialized stores. The company also operates a personnel development and training center to ensure high standards of healthcare service delivery and manages a patient referral service business to facilitate access to its medical expertise. With 580 beds, Bumrungrad Hospital is equipped to handle a large volume of patients, providing comprehensive care across various medical disciplines.
What Products and Services Does BUHPF Offer?
- Operates a large medical center in Bangkok, Thailand.
- Provides diagnostic, therapeutic, and intensive care facilities.
- Offers a wide range of outpatient clinics and centers specializing in various medical disciplines.
- Caters to both domestic and international patients.
- Engages in real estate asset management related to healthcare facilities.
- Provides clinical research services.
- Distributes pharmaceutical and medical goods through specialized stores.
- Operates a personnel development and training center for healthcare services.
How Does BUHPF Make Money?
- Generates revenue through patient fees for medical services.
- Attracts international patients seeking specialized treatments.
- Operates outpatient clinics and centers for various medical specialties.
- Distributes pharmaceutical and medical goods through specialized stores.
What Industry Does BUHPF Operate In?
Bumrungrad Hospital operates within the growing medical care facilities industry, driven by increasing healthcare demand in Thailand and the broader Southeast Asia region. The industry is characterized by technological advancements, rising medical tourism, and an aging population requiring more healthcare services. Competition includes both local and international hospitals, with key players focusing on specialized treatments and patient experience. Bumrungrad distinguishes itself through its international accreditation and focus on medical tourism, catering to a global patient base seeking high-quality healthcare services. The company's ability to adapt to changing healthcare regulations and technological advancements will be crucial for maintaining its competitive edge.
Who Are BUHPF's Key Customers?
- Domestic patients in Thailand seeking medical care.
- International patients seeking specialized treatments and medical tourism.
- Insurance companies and healthcare providers.
- Patients seeking outpatient services and specialized medical centers.
Research confidence
Enough evidence to be useful, with gaps worth knowing about.
- ● Scoring coverage unknown
- ● Price is current
- ● Latest filing 73 days ago
- ● No analyst coverage
- ● Reported in THB, converted to USD
MoonshotScore History
Recorded daily since 2026-08-23 · 19 snapshots
| 2026-08-23 | 47 |
| 2026-08-26 | 47 |
| 2026-08-29 | 47 |
| 2026-09-01 | 47 |
| 2026-09-04 | 47 |
| 2026-09-07 | 47 |
| 2026-09-10 | 47 |
What changed?
The score has stayed at 47.
Over the same 18 days the stock moved +10.1%.
Bumrungrad Hospital Public Company Limited (BUHPF) Valuation Context
Valued at $4.77B, BUHPF is classified as a mid-cap stock.
BUHPF Revenue & Earnings Trend
In Q2 FY2026, BUHPF generated $188.5M in top-line revenue, marking a sequential increase of 0.2%. The company recorded net income of $57.2M, with diluted EPS of $0.07. Quarter-over-quarter revenue has been mixed, typical for a mid-cap company operating in Healthcare. Across the four most recent quarters, BUHPF averaged $0.07 in diluted EPS.
Company Profile
Bumrungrad Hospital Public Company Limited operates in the Medical - Care Facilities industry within the Healthcare sector. It is headquartered in Bangkok, TH. The company is led by CEO Artirat Charukitpipat. BUHPF has traded publicly since 2010.
Key Financial Metrics
Return on equity for Bumrungrad Hospital Public Company Limited stands at 25.1%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 19.6%, showing how much profit it generates from its asset base. BUHPF trades at a trailing price-to-earnings ratio of 20.45, roughly in line with the Healthcare sector average of ~21.50x. Its free cash flow yield is 3.4%, a gauge of the cash the business throws off relative to its market value. A current ratio of 4.48 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 5.1%, the inverse of the P/E and a quick read on earnings relative to price.
Financial Health
Bumrungrad Hospital Public Company Limited's Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of 19.60 places it in the safe zone, indicating low near-term bankruptcy risk.
BUHPF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Strong brand reputation and international accreditation.
- Comprehensive range of medical services and specialized centers.
- Experienced medical professionals and staff.
- Strategic location in Bangkok, a hub for medical tourism.
Bear Case
- Dependence on international patients, making it vulnerable to travel restrictions and economic fluctuations.
- High operating costs associated with maintaining international standards.
- Competition from other healthcare providers in the region.
- Potential regulatory challenges in the healthcare industry.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q2 FY2026 | $189M | $57M | $0.07 |
| Q1 FY2026 | $188M | $54M | $0.06 |
| Q4 FY2025 | $197M | $57M | $0.07 |
| Q3 FY2025 | $197M | $62M | $0.07 |
Q2 FY2026 · filed 30 Jun 2026 · SEC EDGAR →
Based on FMP financials and quantitative analysis · Converted to USD from THB at today's rate
BUHPF Latest News
-
Stocks That Hit 52-Week Lows On Wednesday
· Feb 26, 2020
-
Stocks That Hit 52-Week Lows On Friday
· Oct 4, 2019
BUHPF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for BUHPF.
Price Targets
Wall Street price target analysis for BUHPF.
BUHPF MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for BUHPF; grades run from A+ (80-100) to F (below 30).
Leadership: Artirat Charukitpipat
CEO
Artirat Charukitpipat serves as the CEO of Bumrungrad Hospital Public Company Limited. Her background includes extensive experience in healthcare management and strategic leadership. Prior to her role as CEO, she held various leadership positions within the company, contributing to its growth and development. She possesses a strong understanding of the healthcare industry and a commitment to delivering high-quality patient care. Her expertise spans across operational management, strategic planning, and business development within the healthcare sector.
Track Record: Under Artirat Charukitpipat's leadership, Bumrungrad Hospital has continued to strengthen its position as a leading healthcare provider in Thailand and internationally. She has focused on enhancing patient experience, expanding medical services, and adopting advanced technologies. Her strategic decisions have contributed to the company's financial stability and growth, as evidenced by its consistent profitability and market capitalization. She has also overseen the implementation of various initiatives to improve operational efficiency and enhance the company's competitive edge.
BUHPF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Bumrungrad Hospital Public Company Limited (BUHPF) may not meet the minimum financial standards or disclosure requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial reporting or regulatory oversight, increasing the risk for investors compared to companies listed on major exchanges like NYSE or NASDAQ. This tier often includes companies that are distressed, undergoing restructuring, or have chosen not to comply with higher reporting standards.
- OTC Tier: OTC Other
- Limited Financial Disclosure: Lack of readily available financial information increases investment risk.
- Low Liquidity: Limited trading volume and wide bid-ask spreads can make it difficult to buy or sell shares.
- Regulatory Oversight: Reduced regulatory scrutiny compared to major exchanges increases the risk of fraud or mismanagement.
- Price Volatility: Low trading volume can lead to significant price fluctuations.
- Information Asymmetry: Difficulty in obtaining reliable information about the company's operations and financial performance.
- Verify the company's registration and legal status.
- Attempt to locate and review any available financial statements.
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Consult with a financial advisor to evaluate the risks and potential rewards.
- Check for any news or reports about the company's operations and performance.
- Understand the OTC Other tier and its implications for investor protection.
- Established operations as a healthcare provider in Thailand.
- Market capitalization of $4.77B suggests a significant enterprise.
- Positive profit margin of 29.8% indicates profitability.
- Dividend yield of 8.41% suggests a commitment to shareholder returns.
- Operating history since 1980 indicates some level of stability.
Bumrungrad Hospital Public Company Limited Healthcare Stock: Key Questions Answered
Is BUHPF a good stock?
Stock Expert AI does not rate BUHPF buy, sell or hold. Bumrungrad Hospital Public Company Limited has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns, what the price assumes, and what would prove you wrong.
What does Bumrungrad Hospital Public Company Limited do?
Bumrungrad Hospital Public Company Limited operates as a leading healthcare provider in Thailand, offering a comprehensive range of medical services to both domestic and international patients.
What are the key factors to evaluate for BUHPF?
Evaluate BUHPF on fundamentals, analyst consensus, and risk factors. P/E: 20.45x vs the S&P 500's ~20-25x. The company's low beta of -0.07 suggests it is less volatile than the market, potentially offering a more stable investment option. Not financial advice.
How frequently does BUHPF data refresh on this page?
BUHPF's price was last updated on Sep 11, 2026 and refreshes on page view during U.S. market hours; the quote is a provider snapshot, not an exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven BUHPF's recent stock price performance?
Bumrungrad Hospital Public Company Limited (BUHPF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Strong brand reputation and international accreditation. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider BUHPF overvalued or undervalued right now?
Bumrungrad Hospital Public Company Limited (BUHPF) trades at 20.45x earnings. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Can I buy fractional shares of BUHPF?
Yes, most major brokerages offer fractional shares of Bumrungrad Hospital Public Company Limited (BUHPF) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track BUHPF's earnings and financial reports?
Bumrungrad Hospital Public Company Limited (BUHPF) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Your brokerage can send alerts for BUHPF earnings announcements.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- OTC data may be less reliable than exchange-listed data.